Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat

cnbc.com/2025/05/07/novo-nordisk-nvo-earnings-q1-2025.html

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast amid weaker sales of its blockbuster Wegovy weight loss drugs.
The Danish pharmaceutical giant's net profit came in at 29.03 billion Danish kroner ($4.4 billion)…

This story appeared on cnbc.com, 2025-05-07 05:50:23.
The Entire Business World on a Single Page. Free to Use →